Sage Journals: Discover world-class research

Abstract

Objective:

To examine the relationship between nation-level prevalence of ADHD and COVID-19 prevalence and mortality indices.

Method:

Associations between nation-wise estimated prevalence, crude mortality rates and case-fatality ratios for COVID-19 and estimated prevalence rates for ADHD were examined, controlling for medical conditions known to be associated with COVID-19 outcome, as well as demographic, climate-related, and economic variables.

Results:

Prevalence of ADHD was positively correlated with COVID-19 prevalence and crude mortality rates on bivariate analyses, though the strength of this association was low. On multivariate regression, prevalence of ADHD was negatively associated with COVID-19 prevalence and crude mortality rates, though only the former finding was statistically significant.

Conclusion:

The association between ADHD and COVID-19 prevalence and mortality at a national level is inconsistent, modest, and may be largely due to confounding factors such as age, lifestyle factors, and medical comorbidities.

Keywords

COVID-19 ADHD prevalence crude mortality rate comorbidity

Get full access to this article

View all access options for this article.

References

Akoglu

(2018). User’s guide to correlation coefficients. Turkish Journal of Emergency Medicine, 18, 91–93. https://doi.org/10.1016/j.tjem.2018.08.001

Anand

Colpo

G. D.

Zeni

C. P.

Teixeira

A. L.

(2017). Attention-deficit/hyperactivity disorder and inflammation: What does current knowledge tell us? A systematic review. Frontiers in Psychiatry, 8, 228. https://doi.org/10.3389/fpsyt.2017.00228

Arbel

Fialkoff

Kerner

(2020). Can increased recovery rates from coronavirus be explained by prevalence of ADHD? An analysis at the US statewide level. Journal of Attention Disorders. Advance online publication. https://doi.org/10.1177/1087054720959707

Arildskov

T. W.

Virring

Thomsen

P. H.

Østergaard

S. D.

(2021). Testing the evolutionary advantage theory of attention-deficit/hyperactivity disorder traits. European Child & Adolescent Psychiatry. Advance online publication. https://doi.org/10.1007/s00787-020-01692-4

Azeredo

Moreira

Barbosa

(2018). ADHD, CD, and ODD: Systematic review of genetic and environmental risk factors. Research in Developmental Disabilities, 82, 10–19. https://doi.org/10.1016/j.ridd.2017.12.010

Benzano

Ornell

Schuch

J. B.

Pechansky

Sordi

A. O.

von Diemen

Kessler

F. H. P.

(2021). Clinical vulnerability for severity and mortality by COVID-19 among users of alcohol and other substances. Psychiatry Research, 300, 113915. https://doi.org/10.1016/j.psychres.2021.113915

Bruni

Giallonardo

Sacco

Ferri

Melegari

M. G.

(2021). The impact of lockdown on sleep patterns of children and adolescents with ADHD. Journal of Clinical Sleep Medicine. Advance online publication. https://doi.org/10.5664/jcsm.9296

Caye

Spadini

A. V.

Karam

R. G.

Grevet

E. H.

Rovaris

D. L.

Bau

C. H. D.

Rohde

L. A.

Kieling

(2016). Predictors of persistence of ADHD into adulthood: A systematic review of the literature and meta-analysis. European Child & Adolescent Psychiatry, 25(11), 1151–1159. https://doi.org/10.1007/s00787-016-0831-8

Chang

J. P.

K. P.

Mondelli

Pariante

C. M.

(2021). Cortisol and inflammatory biomarker levels in youths with attention deficit hyperactivity disorder (ADHD): Evidence from a systematic review with meta-analysis. Translational Psychiatry, 11, 430. https://doi.org/10.1038/s41398-021-01550-0

10.

Chang

J. P.-C.

Mondelli

Satyanarayanan

S. K.

Chiang

Y.-J.

Chen

H.-T.

K. P.

Pariante

C. M.

(2020). Cortisol, inflammatory biomarkers and neurotrophins in children and adolescents with attention deficit hyperactivity disorder (ADHD) in Taiwan. Brain, Behavior, and Immunity, 88, 105–113. https://doi.org/10.1016/j.bbi.2020.05.017

11.

Chen

Prettner

Kuhn

Geldsetzer

Wang

Bärnighausen

Bloom

D. E.

(2021). Climate and the spread of COVID-19. Scientific Reports, 11(1), 9042. https://doi.org/10.1038/s41598-021-87692-z

12.

Coelho

C. M.

Suttiwan

Arato

Zsido

A. N.

(2020). On the nature of fear and anxiety triggered by COVID-19. Frontiers in Psychology, 11, 581314. https://doi.org/10.3389/fpsyg.2020.581314

13.

Corrao

Rea

Blangiardo

G. C.

(2021). Lessons from COVID-19 mortality data across countries. Journal of Hypertension, 39, 856–860. https://doi.org/10.1097/HJH.0000000000002833

14.

de Jong

Newhouse

S. J.

Patel

Lee

Dempster

Curtis

Paya-Cano

Murphy

Wilson

C. E.

Horder

Mendez

M. A.

Asherson

Rivera

Costello

Maltezos

Whitwell

Pitts

Tye

Ashwood

K. L.

, . . ., Breen

. (2016). Immune signatures and disorder-specific patterns in a cross-disorder gene expression analysis. The British Journal of Psychiatry, 209(3), 202–208. https://doi.org/10.1192/bjp.bp.115.175471

15.

Dickins

T. E.

Schalz

(2020). Food shopping under risk and uncertainty. Learning and Motivation, 72, 101681. https://doi.org/10.1016/j.lmot.2020.101681

16.

Dong

Gardner

(2020). An interactive web-based dashboard to track COVID-19 in real time. The Lancet Infectious Diseases, 20(5), 533–534. https://doi.org/10.1016/S1473-3099(20)30120-1

17.

Dorjee

Kim

Bonomo

Dolma

(2020). Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients. PLoS One, 15(12), e0243191. https://doi.org/10.1371/journal.pone.0243191

18.

Elsadek

A. E.

Al-Shokary

A. H.

Abdelghani

W. E.

Kamal

N. M.

Ibrahim

A. O.

El-Shorbagy

H. H.

Suliman

H. A.

Barseem

N. F.

Abdel Maksoud

Y. H.

Azab

S. M.

Nour

Din

D. M.

(2020). Serum levels of interleukin-6 and tumor necrosis factor alpha in children with attention-deficit hyperactivity disorder. Journal of Pediatric Neurosciences, 15(4), 402–408. https://doi.org/10.4103/jpn.JPN_1_20

19.

Faraone

S.V.

Banaschewski

Coghill

Zheng

Biederman

Bellgrove

M. A.

Newcorn

J. H.

Gignac

Al Saud

N. M.

Manor

Rohde

L. A.

Yang

Cortese

Almagor

Stein

M. A.

Albatti

T. H.

Aljoudi

H. F.

Alqahtani

M. M. J.

Asherson

, . . ., Wang

(2021). The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience and Biobehavioral Reviews, 128, 789–818. https://doi.org/10.1016/j.neubiorev.2021.01.022

20.

Gallo

E. F.

Posner

(2016). Moving towards causality in attention-deficit hyperactivity disorder: Overview of neural and genetic mechanisms. The Lancet Psychiatry, 3(6), 555–567. https://doi.org/10.1016/S2215-0366(16)00096-1

21.

Gjervan

Torgersen

Nordahl

H. M.

Rasmussen

(2012). Functional impairment and occupational outcome in adults with ADHD. Journal of Attention Disorders, 16(7), 544–552. https://doi.org/10.1177/1087054711413074

22.

Global Burden of Disease Collaborative Network. (2020). Global Burden of Disease Study 2019 (GBD 2019) results. Institute for Health Metrics and Evaluation. https://ghdx.healthdata.org/gbd-results-tool

23.

Hak

de Vries

T. W.

Hoekstra

P. J.

Jick

S. S.

(2013). Association of childhood attention-deficit/hyperactivity disorder with atopic diseases and skin infections? A matched case-control study using the General Practice Research Database. Annals of Allergy Asthma & Immunology, 111(2), 102–106.e2. https://doi.org/10.1016/j.anai.2013.05.023

24.

Hou

Zhang

Shi

Diao

Wang

Yang

(2021). Smoking is independently associated with an increased risk for COVID-19 mortality: A systematic review and meta-analysis based on adjusted effect estimates. Nicotine & Tobacco Research, 23, 1947–1951. https://doi.org/10.1093/ntr/ntab112

25.

Huntley

Young

(2014). Alcohol and substance use history among ADHD adults: The relationship with persistent and remitting symptoms, personality, employment, and history of service use. Journal of Attention Disorders, 18(1), 82–90. https://doi.org/10.1177/1087054712446171

26.

Johanna

Citrawijaya

Wangge

(2020). Mass screening vs lockdown vs combination of both to control COVID-19: A systematic review. Journal of Public Health Research, 9(4), 2011. https://doi.org/10.4081/jphr.2020.2011

27.

Johns Hopkins University of Medicine. (2021). Mortality analyses. Retrieved May 3, 2021, from https://coronavirus.jhu.edu/data/mortality.

28.

Karcioglu Batur

Hekim

. (2021). Correlation between interleukin gene polymorphisms and current prevalence and mortality rates due to novel coronavirus disease 2019 (COVID-2019) in 23 countries. Journal of Medical Virology, 93(10), 5853–5863. https://doi.org/10.1002/jmv.27127

29.

Kirova

A.-M.

Kelberman

Storch

DiSalvo

Woodworth

K. Y.

Faraone

S. V.

Biederman

(2019). Are subsyndromal manifestations of attention deficit hyperactivity disorder morbid in children? A systematic qualitative review of the literature with meta-analysis. Psychiatry Research, 274, 75–90. https://doi.org/10.1016/j.psychres.2019.02.003

30.

Koh

Cunningham

A. C.

(2020). Counting coronavirus disease 2019 (COVID-19) cases: Case definitions, screened populations and testing techniques matter. Annals of the Academy of Medicine, Singapore, 49(3), 161–165.

31.

Krahel

Paszynska

Slopien

Gawriolek

Otulakowska-Skrzynska

Rzatowski

Hernik

Hanć

Bryl

Szczesniewska

Bilska

Duda

Tyszkiewicz-Nwafor

Dmitrzak-Weglarz

(2021). Stress/immune biomarkers in saliva among children with ADHD status. International Journal of Environmental Research and Public Health, 18(2), 769. https://doi.org/10.3390/ijerph18020769

32.

D. J.

Chen

Y.-L.

Hsiao

R. C.

Chen

H.-L.

Yen

C.-F.

(2021). Risk of respiratory infectious diseases and the role of methylphenidate in children with attention-deficit/hyperactivity disorder: A population-based cohort study. International Journal of Environmental Research and Public Health, 18(11), 5824. https://doi.org/10.3390/ijerph18115824

33.

McLennan

J. D.

(2016). Understanding attention deficit hyperactivity disorder as a continuum. Canadian Family Physician Medecin de Famille Canadien, 62, 979–982.

34.

Merzon

Manor

Rotem

Schneider

Vinker

Golan Cohen

Lauden

Weizman

Green

(2021a). ADHD as a risk factor for infection with COVID-19. Journal of Attention Disorders, 25, 1783–1790. https://doi.org/10.1177/1087054720943271

35.

Merzon

Weiss

M. D.

Cortese

Rotem

Schneider

Craig

S. G.

Vinker

Golan Cohen

Green

Ashkenazi

Weizman

Manor

(2021b). The association between ADHD and the severity of COVID-19 infection. Journal of Attention Disorders. Advance online publication. https://doi.org/10.1177/10870547211003659

36.

Pinzone

De Rossi

Trabucchi

Lester

Girardi

Pompili

(2019). Temperament correlates in adult ADHD: A systematic review. Journal of Affective Disorders, 252, 394–403. https://doi.org/10.1016/j.jad.2019.04.006

37.

Pollak

Shoham

Dayan

Gabrieli-Seri

Berger

(2021a). Symptoms of ADHD predict lower adaptation to the COVID-19 outbreak: financial decline, low adherence to preventive measures, psychological distress, and illness-related negative perceptions. Journal of Attention Disorders. Advance online publication. https://doi.org/10.1177/10870547211027934

38.

Pollak

Shoham

Dayan

Gabrieli-Seri

Berger

(2021b). Background and concurrent factors predicting non-adherence to public health preventive measures during the chronic phase of the COVID-19 pandemic. Journal of Public Health. Advance online publication. https://doi.org/10.1093/pubmed/fdab214

39.

Rajgor

D. D.

Lee

M. H.

Archuleta

Badgasarian

Quek

S. C.

(2020). The many estimates of the COVID-19 case fatality rate. The Lancet. Infectious Diseases, 20(7), 776–777. https://doi.org/10.1016/S1473-3099(20)30244-9

40.

Rajkumar

R. P.

(2021). Cross-national variations in COVID-19 mortality: The role of diet, obesity and depression. Diseases, 9(2), 36. https://doi.org/10.3390/diseases9020036

41.

Sagar

Reifler

Rossi

Miller

N. S.

Sinha

White

L. F.

Mizgerd

J. P.

(2021). Recent endemic coronavirus infection is associated with less-severe COVID-19. The Journal of Clinical Investigation, 131(1), e143380. https://doi.org/10.1172/JCI143380

42.

Sajadi

M. M.

Habibzadeh

Vintzileos

Shokouhi

Miralles-Wilhelm

Amoroso

(2020). Temperature, humidity, and latitude analysis to estimate potential spread and seasonality of coronavirus disease 2019 (COVID-19). JAMA Network Open, 3(6), e2011834. https://doi.org/10.1001/jamanetworkopen.2020.11834

43.

Shi

Wang

Xia

Xie

Lin

. (2021). Predictors of mortality in patients with coronavirus disease 2019: a systematic review and meta-analysis. BMC Infectious Diseases, 21(1), 663. https://doi.org/10.1186/s12879-021-06369-0

44.

Swansburg

Hai

MacMaster

F. P.

Lemay

J -F.

(2021). Impact of COVID-19 on lifestyle habits and mental health symptoms in children with attention-deficit/hyperactivity disorder in Canada. Paediatrics & Child Health, 26(5), e199–e207. https://doi.org/10.1093/pch/pxab030

45.

Thakur

Dubey

Benitez

Torres

J. P.

Reddy

Shokar

Aung

Mukherjee

Dwivedi

A. K.

(2021). A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19. Scientific Reports, 11(1), 8562. https://doi.org/10.1038/s41598-021-88130-w

46.

The World Bank. (2021). World Bank Open data. Retrieved September 1, 2021, from https://data.worldbank.org

47.

Thomas

Sanders

Doust

Beller

Glasziou

(2015). Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics, 135(4), e994–e1001. https://doi.org/10.1542/peds.2014-3482

48.

van den Burg

Crunelle

C. L.

Matthys

van Den Brink

. (2019). Diagnosis and treatment of patients with comorbid substance use disorder and adult attention-deficit and hyperactivity disorder: A review of recent publications. Current Opinion in Psychiatry, 32(4), 300–306. https://doi.org/10.1097/YCO.0000000000000513

49.

van Dongen

Zilhao

N.R.

Sugden

Hannon

E.J

Mill

Caspi

, BIOS Consortium, Agnew-Blais

Arseneault

Corcoran

D. L.

Moffitt

T. E.

Poulton

Franke

Boomsma

D.I

. (2019). Epigenome-wide association study of attention-deficit/hyperactivity disorder symptoms in adults. Biological Psychiatry, 86(8), 599–607. https://doi.org/10.1016/j.biopsych.2019.02.016

50.

Williams

Taylor

(2006). The evolution of hyperactivity, impulsivity and cognitive diversity. Journal of the Royal Society Interface, 3, 399–413. https://doi.org/10.1098/rsif.2005.0102

51.

World Atlas. (2020). World map/world atlas. Retrieved August 28, 2021, from https://worldatlas.com

52.

World Health Organization. (2021). Noncommunicable diseases: Risk factors. Retrieved May 3, 2021, from https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/ncd-risk-factors

53.

Yonas

Alwi

Pranata

Huang

Lim

M. A.

Yamin

Virani

S.S.

(2020). Elevated interleukin levels are associated with higher severity and mortality in COVID-19: A systematic review, meta-analysis, and meta-regression. Diabetes & Metabolic Syndrome, 14(6), 2219–2230. https://doi.org/10.1016/j.dsx.2020.11.011

Is There a Relationship Between ADHD and COVID-19 Prevalence and Mortality Indices? An Analysis of Data From 156 Countries

Abstract

Objective:

Method:

Results:

Conclusion:

Keywords

Get full access to this article

References